Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group
Anna Patrikidou(Institut Gustave Roussy), Julien Dômont(Institut Gustave Roussy), Sylvie Chabaud(Centre Léon Bérard), Isabelle Ray‐Coquard(Centre Léon Bérard), J.M. Coindre(Institut Bergonié), B. Bui-Nguyen(Institut Bergonié), Antoine Adenis(Centre Oscar Lambret), María Rios(Délégation Centre-Est), François Bertucci(Institut Paoli-Calmettes), Florence Duffaud(Hôpital de la Timone), Christine Chevreau(Institut Claudius Regaud), Didier Cupissol(Institut de Recherche en Cancérologie de Montpellier), David Pérol(Centre Léon Bérard), Jean-François Emile(Hôpital Ambroise-Paré), Jean‐Yves Blay(Centre Léon Bérard), Axel Le Cesne(Institut Gustave Roussy)
Cited by 82Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis